Inventor
THOMAS CRAIG
US12 patents
⚠️ This page may combine multiple inventors who share the name “THOMAS CRAIG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
4 patentsUS9532989B2Jan 3, 2017
Oxadiazolo[3,2-A]pyrimidines and thiadiazolo[3,2-A]pyrimidines
US HEALTH2 citations70
US11613514B2Mar 28, 2023
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
US HEALTH2 citations69
US10919842B2Feb 16, 2021
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
US HEALTH4 citations69
US12473251B2Nov 18, 2025
Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine
US HEALTH0 citations59
UNIV MARYLAND
2 patentsUS11897875B2Feb 13, 2024
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type a receptors as fast acting treatment for depression and mood disorders
UNIV MARYLAND0 citations58
US11459320B2Oct 4, 2022
Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders
UNIV MARYLAND0 citations58